A Randomized, Multicenter Study of DSP-7888 Dosing Emulsion in Combination with Bevacizumab versus Bevacizumab Alone in Patients with Recurrent or Progressive Glioblastoma following Initial Therapy (17058)

A Randomized, Multicenter Study of DSP-7888 Dosing Emulsion in Combination with Bevacizumab versus Bevacizumab Alone in Patients with Recurrent or Progressive Glioblastoma following Initial Therapy (17058)

Trial Category:
Brain/Neuro
Phase
II
Contact(s)
Mary Beth Wilwerding, RN
Phone
402-991-8070
Fax
402-991-8850
Location(s)
Nebraska Cancer Specialists, Omaha, NE

This study is looking at a new treatment alone or combined with the drug Bevacizumab which has been used in glioblastoma.  This study is for patients who are experiencing tumor progression after treatment. 

 
 
Become a NOS Member Today!
 

Platinum Corporate Members

Gold Corporate Members